No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
AEE240816C70000
- 5.30
- -0.70-11.67%
15min DelayClose Jul 19 15:59 ET
5.60High5.29Low
5.60Open6.00Pre Close203 Volume5 Open Interest70.00Strike Price108.33KTurnover24.05%IV0.64%PremiumAug 16, 2024Expiry Date4.82Intrinsic Value100Multiplier25DDays to Expiry0.48Extrinsic Value100Contract SizeAmericanOptions Type0.8704Delta0.0440Gamma13.86Leverage Ratio-0.0281Theta0.0425Rho12.06Eff Leverage0.0421Vega
Intraday
- 5D
- Daily
News
Long History Of Dividend Growth & High Yields: Ameren, Flowers Foods, And Altria
6 Analysts Have This To Say About Ameren
Analysts' ratings for Ameren (NYSE:AEE) over the last quarter vary from bullish to bearish, as provided by 6 analysts.The table below summarizes their recent ratings, showcasing the evolving
Ameren Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/19/2024 16.29% UBS $81 → $87 Upgrades Neutral → Buy 06/24/2024 -3.76% Morgan Stanley $76 → $72
Express News | Ameren Corp : UBS Raises to Buy From Neutral
Express News | Ameren Corp : UBS Raises Target Price to $87 From $81
UBS Initiates Ameren(AEE.US) With Buy Rating, Announces Target Price $87
UBS analyst William Appicelli initiates coverage on $Ameren(AEE.US)$ with a buy rating, and sets the target price at $87.According to TipRanks data, the analyst has a success rate of 25.0% and a
Comments
The share price doesn't reflect EPS growth, and revenue drop may hint at lower earnings. The sell-off could be a chance for long-term investors, but checking fundamental data for growth signs is crucial. Beware of 2 warning signs with Ameren.
Investors in Ameren (NYSE:AEE) Have Unfortunately Lost 8.0% Over the Last Year 1
Significant insider selling at Ameren and lack of insider purchases may suggest shares are not cheap. Despite profitability and growth, low insider ownership could be a cause for caution.
Ameren's ROE is unimpressive given its high debt level. A high-quality business should achieve a high ROE without debt. The company's significant debt use to boost returns hasn't resulted in a high ROE, a concerning sign.
Ameren's P/E ratio, paralleling with the median, seems unusual considering its limited growth expectations. The stock may risk decline as the market doesn't appear to anticipate the modest earnings. Without enhancement in conditions, the current price levels appear unreasonable.
Ameren's total shareholder return outpaced its share performance over 5 years. The recent sell-off might be an opportunity amidst its strong long-term earnings trend.
Read more